Concepedia

K. Raja Reddy

KR

23

Publications

1.3K

Citations

17

H-Index

1987

Active since

Affiliations

Torrey Pines Institute For Molecular Studies(Current)

Harvard University

University of Hyderabad

Mapp Biopharmaceutical (United States)

Fate Therapeutics (United States)

K. Raja Reddy is an author at Torrey Pines Institute For Molecular Studies specializing in pharmacology, medicine, and biochemistry.

Top concepts

Publications per year

1987–2021

23

Publications

23

Discovery of Cyclic Boronic Acid QPX7728, an Ultrabroad-Spectrum Inhibitor of Serine and Metallo-β-lactamases

Scott J. Hecker, K. Raja Reddy, Olga Lomovskaya et al. · Journal of Medicinal Chemistry · 2020 · 200 citations · Full text

MB06322 (CS-917): A potent and selective inhibitor of fructose 1,6-bisphosphatase for controlling gluconeogenesis in type 2 diabetes

Mark D. Erion, Paul D. van Poelje, Qun Dang et al. · Proceedings of the National Academy of Sciences · 2005 · 162 citations · Full text

, , +20

Design, Synthesis, and Characterization of a Series of Cytochrome P<sub>450</sub>3A-Activated Prodrugs (HepDirect Prodrugs) Useful for Targeting Phosph(on)ate-Based Drugs to the Liver<sup>§</sup>

Mark D. Erion, K. Raja Reddy, Serge H. Boyer et al. · Journal of the American Chemical Society · 2004 · 157 citations

Total synthesis of hemibrevetoxin B and (7a.alpha.)-epi-hemibrevetoxin B

K. C. Nicolaou, K. Raja Reddy, G. SKOKOTAS et al. · Journal of the American Chemical Society · 1993 · 116 citations

, , +13

Discovery of Potent and Specific Fructose-1,6-Bisphosphatase Inhibitors and a Series of Orally-Bioavailable Phosphoramidase-Sensitive Prodrugs for the Treatment of Type 2 Diabetes

Qun Dang, Srinivas Rao Kasibhatla, K. Raja Reddy et al. · Journal of the American Chemical Society · 2007 · 95 citations

, , +17

Rows per page

1–5 of 23